The Regulator

Two days: that is how long a federal judge in Massachusetts has before deciding whether to block a rule that narrows who counts as too medically frail to have to prove they are working to keep their Medicaid coverage. The U.S. District Court for the District of Massachusetts is scheduled to hold a hearing July 28, 2026 on a motion for preliminary injunction in Commonwealth of Massachusetts et al. v. Oz et al., filed June 29, 2026 by 25 states and the District of Columbia against the Department of Health and Human Services and the Centers for Medicare and Medicaid Services. The states argue an interim final rule the agencies published June 3, 2026 unlawfully narrows the “medically frail” exemption Congress wrote into this year’s Medicaid work-requirements law, adding a “significant impairment” standard not in the statute and excluding people in stable substance-use-disorder recovery of five years or more. Massachusetts Attorney General Andrea Joy Campbell, who is co-leading the coalition, said the rule “threatens access to healthcare for our most vulnerable residents and families.” The underlying work requirements take effect January 1, 2027, with stricter documentation rules phasing in a year later, so Tuesday’s ruling will shape whether states build compliance systems around the narrower standard while the broader case proceeds. Confidence: High on the case posture, filing date and hearing date, since Massachusetts’s own complaint and public statements confirm them directly. Low on the outcome, since the hearing has not occurred. Sources: AG Campbell Sues Trump Administration Over Unlawful Medicaid Work Requirements Rule, Massachusetts Attorney General’s Office, New Federal Medicaid Work Reporting Requirements Rule Threatens Coverage for Vulnerable Americans, Georgetown University Center for Children and Families.

45 to 0: that is the vote by which a House committee sent a hospital price-transparency bill to the floor this week, one of two competing transparency bills to clear Congress within 24 hours of each other. The House Energy and Commerce Committee voted 45 to 0 on July 21, 2026 to advance H.R. 9393, the Lower Costs, More Transparency Act of 2026, which would require hospitals to post standard charges, discounted cash prices and negotiated insurer rates for at least 300 common “shoppable” services in a consumer-friendly format, plus new disclosure rules for clinical laboratories, ambulatory surgery centers and pharmacy benefit managers, the drug-pricing middlemen insurers hire to negotiate with pharmacies. A day earlier, the Senate Health, Education, Labor and Pensions Committee voted 21 to 1 to advance a competing bill, S. 2355, the Patients Deserve Price Tags Act, which would require hospitals, surgery centers, imaging centers and labs to disclose actual negotiated rates and let patients get itemized bills; only Senator Rand Paul voted no. Confidence: High on both committee votes and the bills’ provisions, since the committees’ own records confirm them directly. Low on floor prospects, since neither chamber has scheduled a vote. Sources: The House Committee on Energy and Commerce Advances 17 Bills to the Full House of Representatives, House Committee on Energy and Commerce, Text, S.2355, Patients Deserve Price Tags Act, Congress.gov.

7,100 percent: that is how much Medicare spending on lab-grown skin substitutes grew in six years, and this week a House subcommittee grilled witnesses on why last year’s crackdown has not stopped the fraud. The House Oversight and Government Reform Committee’s health subcommittee held a roundtable July 21, 2026 titled “Medicare Fraud: Examining the Explosive Growth in Skin Substitute Spending,” with Chairman Glenn Grothman citing Medicare Part B spending on skin substitute products, biologic dressings applied to help chronic wounds heal, that grew from roughly 200 million dollars in 2019 to more than 14.4 billion dollars in 2025. The roundtable, attended only by Republican members, came eight months after the Centers for Medicare and Medicaid Services finalized a rule reclassifying most skin substitutes as “incident-to” supplies and setting a single payment rate of 127.14 dollars per square centimeter, effective January 1, 2026, which the agency projected would cut Part B spending on the category by nearly 90 percent; witnesses discussed whether that reform is sufficient and what role accountable care organizations should play in flagging fraudulent claims. Confidence: High on the spending figures and the roundtable’s occurrence, since the committee’s own release confirms them. Low on whether the roundtable produces legislation, since none has been introduced. Sources: Grothman Leads Roundtable on Tackling Medicare Fraud in Skin Substitutes Funding, House Committee on Oversight and Government Reform, CMS Modernizes Payment Accuracy and Significantly Cuts Spending Waste, Centers for Medicare and Medicaid Services.

270 days: that is the longest window some states give Medicaid managed-care insurers to report suspected provider fraud, and a federal watchdog says that is only one of the gaps letting bad actors bill undetected. The Department of Health and Human Services’ Office of Inspector General reported July 21, 2026 that state Medicaid agencies’ contracts with managed care organizations, the private plans that run most states’ Medicaid programs, vary widely in how they require insurers to flag suspected provider fraud, with referral deadlines ranging from 1 day to 270 days and some states setting no deadline at all; other states’ contracts do not specify any consequence if a plan simply fails to comply, and several states give plans no training or feedback on their fraud referrals. OIG issued four recommendations to CMS, including requiring all managed-care contracts to mandate prompt fraud referrals and specifying enforcement consequences for noncompliance; CMS concurred with the first two recommendations and only partially addressed the other two. Confidence: High on the findings and recommendations, since OIG’s own report confirms them directly. Source: States Have Missed Some Opportunities To Improve Medicaid Managed Care Organizations’ Provider Fraud Referrals, HHS Office of Inspector General.

6 years: that is how long CMS just extended a private accreditor’s power to certify Medicare Advantage plans on the government’s behalf, covering the insurance product more than half of Medicare’s enrollees now choose. CMS announced in a Federal Register notice published July 27, 2026 that it approved the National Committee for Quality Assurance’s application to renew its “deeming authority,” letting NCQA continue inspecting and certifying Medicare Advantage health maintenance organizations and preferred provider organizations as meeting federal Medicare requirements in place of a direct CMS survey, for a new six-year term. Deeming authority means a Medicare Advantage plan accredited by NCQA is automatically treated as meeting most of CMS’s own conditions of participation, a status insurers rely on to avoid duplicative federal inspections. Confidence: High on the renewal and its term, since the Federal Register notice confirms it directly. Low on how NCQA’s specific standards compare to CMS’s own criteria in practice, since the notice does not detail the underlying review. Source: Medicare Program; Approved Renewal of Deeming Authority of the National Committee for Quality Assurance for Medicare Advantage Health Maintenance Organizations and Preferred Provider Organizations, Federal Register.

72 million dollars: that is how much Massachusetts regulators say they saved residents and businesses on 2027 health insurance premiums by pushing back on what seven insurers first asked to charge. The Massachusetts Division of Insurance approved 2027 merged-market health insurance rates July 22, 2026 after renegotiating lower increases with seven insurers, Blue Cross Blue Shield of Massachusetts HMO Blue, Harvard Pilgrim Health Care, Health New England, Mass General Brigham Health Plan, Tufts Health Public Plans, UnitedHealthcare and WellSense Health Plan, and rejecting Fallon Community Health Plan’s initial request for a 25.7 percent increase outright as excessive. Governor Maura Healey’s office said the renegotiated rates will save an estimated 72 million dollars for roughly 670,000 residents and businesses covered in the state’s merged individual and small-group insurance market, though average premiums are still rising for 2027. Confidence: dropped, since the Massachusetts Division of Insurance’s own announcement returned an access block for this issue and this account rests on WWLP and Becker’s Payer Issues reporting that quotes the state’s figures directly. Sources: Governor Healey: Insurance Commissioner’s Actions Save $72 Million for Massachusetts Residents, Businesses, Massachusetts Division of Insurance, Governor Healey announces $72 million in health care savings for 2027, WWLP.